These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9272406)

  • 1. Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide.
    Bindschedler M; Degen P; Flesch G; de Gasparo M; Preiswerk G
    Eur J Clin Pharmacol; 1997; 52(5):371-8. PubMed ID: 9272406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects.
    Müller P; Flesch G; de Gasparo M; Gasparini M; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):441-9. PubMed ID: 9342579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
    Azizi M; Bissery A; Lamarre-Cliche M; Ménard J
    Hypertension; 2004 Apr; 43(4):785-90. PubMed ID: 15023936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.
    Ayalasomayajula S; Schuehly U; Pal P; Chen F; Zhou W; Sunkara G; Langenickel TH
    Br J Clin Pharmacol; 2018 May; 84(5):926-936. PubMed ID: 29318651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA; Helmy SA
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
    Maillard MP; Würzner G; Nussberger J; Centeno C; Burnier M; Brunner HR
    Clin Pharmacol Ther; 2002 Jan; 71(1):68-76. PubMed ID: 11823759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
    Schmidt EK; Antonin KH; Flesch G; Racine-Poon A
    Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects.
    Müller P; Cohen T; de Gasparo M; Sioufi A; Racine-Poon A; Howald H
    Eur J Clin Pharmacol; 1994; 47(3):231-45. PubMed ID: 7867676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.
    Chen CL; Desai-Krieger D; Ortiz S; Kerolous M; Wright HM; Ghahramani P
    Am J Ther; 2015; 22(5):e130-40. PubMed ID: 25853236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, open-label, 5-way crossover study to evaluate the pharmacokinetic/pharmacodynamic interaction between furosemide and the non-steroidal anti-inflammatory drugs diclofenac and ibuprofen in healthy volunteers.
    Paterson CA; Jacobs D; Rasmussen S; Youngberg SP; McGuinness N
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):477-90. PubMed ID: 21781648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.
    Jung JA; Noh YH; Jin S; Kim MJ; Kim YH; Jung JA; Lim HS; Bae KS
    Clin Ther; 2012 Apr; 34(4):958-65. PubMed ID: 22410289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man.
    Flesch G; Müller P; Lloyd P
    Eur J Clin Pharmacol; 1997; 52(2):115-20. PubMed ID: 9174680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.